November 15, 2025

NGS Streamlines Clonal Detection in Plasma Cells

Research presented at AMP 2025 shows high-sensitivity sequencing may eliminate CD138 selection and speed identification of high-risk patients.

Conexiant

November 15, 2025

Optimizing Diagnostic Stewardship: The Clinician’s Perspective

Recommendations focus on reducing unnecessary testing and treatment while improving diagnostic accuracy.

Conexiant

November 15, 2025

AI Models Predict CNS Tumors From Spinal Fluid

At AMP 2025, a South Korean research team outlined a multimodal approach that integrates CSF, DNA, and MRI data to enable early, noninvasive tumor classification.

Conexiant

November 15, 2025

New Genetic Test Targets Rare X-Linked Movement Disorder

A targeted assay, presented at AMP 2025, identifies disease-specific TAF1 variants that standard panels often miss.

Conexiant

November 15, 2025

Optimizing Diagnostic Stewardship: The Lab Director’s Perspective

Programs that refine test ordering, performance, and reporting can reduce unnecessary treatments and enhance lab efficiency.

Conexiant

November 14, 2025

New ddPCR Test Detects Lyme Disease More Accurately

The droplet digital PCR assays, developed at Dartmouth, could improve diagnosis of Lyme disease.

Conexiant

November 14, 2025

Streamlining VUS Classification in Clinical Genomics

New variant classification standards and data-sharing initiatives will help laboratories and clinicians focus on actionable variants.

Conexiant

November 14, 2025

Michael Laposata Receives Champion for Innovation Award

At AMP’s annual meeting, the organization also honored Alexis Carter, Dara Aisner, and Lawrence Jennings for their contributions to laboratory medicine and molecular pathology.

Conexiant

November 14, 2025

RNA Testing Uncovers Hidden Gene Fusions in AML

Michigan team finds cryptic leukemia-defining rearrangements missed by standard cytogenetics.

Conexiant